M&G plc (LON:MNG)
London
· Delayed Price · Currency is GBP · Price in GBp 203.40
-2.20 (-1.07%)
Mar 28, 2025, 5:42 PM BST
M&G plc Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Premiums & Annuity Revenue | 4,095 | 3,887 | 3,325 | 3,765 | 4,869 | Upgrade
|
| Total Interest & Dividend Income | 726 | 2,053 | -4,326 | 5,205 | 6,626 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 6,566 | 3,559 | Upgrade
|
| Other Revenue | 638 | 340 | 2,744 | 1,098 | 1,092 | Upgrade
|
| Total Revenue | 5,459 | 6,280 | 1,743 | 16,634 | 16,146 | Upgrade
|
| Revenue Growth (YoY) | -13.07% | 260.30% | -89.52% | 3.02% | -51.30% | Upgrade
|
| Policy Benefits | 2,888 | 2,893 | 2,921 | 13,083 | 10,764 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 73 | 56 | 26 | - | - | Upgrade
|
| Selling, General & Administrative | 1,863 | 1,727 | 1,863 | 2,347 | 2,319 | Upgrade
|
| Provision for Bad Debts | 15 | -2 | -31 | - | - | Upgrade
|
| Other Operating Expenses | 38 | -20 | 17 | - | - | Upgrade
|
| Total Operating Expenses | 4,877 | 4,654 | 4,796 | 15,430 | 13,083 | Upgrade
|
| Operating Income | 582 | 1,626 | -3,053 | 1,204 | 3,063 | Upgrade
|
| Interest Expense | -419 | -366 | -298 | -321 | -320 | Upgrade
|
| Earnings From Equity Investments | 24 | 23 | 38 | 81 | -55 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -120 | -178 | Upgrade
|
| Other Non Operating Income (Expenses) | 363 | -226 | 550 | -1,019 | 109 | Upgrade
|
| EBT Excluding Unusual Items | 550 | 1,057 | -2,763 | -175 | 2,619 | Upgrade
|
| Merger & Restructuring Charges | -180 | -226 | -228 | -222 | -148 | Upgrade
|
| Impairment of Goodwill | -149 | -17 | -25 | - | -15 | Upgrade
|
| Asset Writedown | -76 | -65 | -3 | 1,185 | -851 | Upgrade
|
| Pretax Income | 145 | 749 | -3,019 | 788 | 1,605 | Upgrade
|
| Income Tax Expense | 492 | 440 | -964 | 696 | 463 | Upgrade
|
| Earnings From Continuing Ops. | -347 | 309 | -2,055 | 92 | 1,142 | Upgrade
|
| Net Income to Company | -347 | 309 | -2,055 | 92 | 1,142 | Upgrade
|
| Minority Interest in Earnings | -13 | -12 | -13 | -9 | -4 | Upgrade
|
| Net Income | -360 | 297 | -2,068 | 83 | 1,138 | Upgrade
|
| Net Income to Common | -360 | 297 | -2,068 | 83 | 1,138 | Upgrade
|
| Net Income Growth | - | - | - | -92.71% | 1.61% | Upgrade
|
| Shares Outstanding (Basic) | 2,388 | 2,350 | 2,474 | 2,542 | 2,563 | Upgrade
|
| Shares Outstanding (Diluted) | 2,388 | 2,396 | 2,474 | 2,575 | 2,587 | Upgrade
|
| Shares Change (YoY) | -0.33% | -3.15% | -3.92% | -0.46% | -0.54% | Upgrade
|
| EPS (Basic) | -0.15 | 0.13 | -0.84 | 0.03 | 0.44 | Upgrade
|
| EPS (Diluted) | -0.15 | 0.12 | -0.84 | 0.03 | 0.44 | Upgrade
|
| EPS Growth | - | - | - | -92.73% | 2.25% | Upgrade
|
| Free Cash Flow | 388 | 1,223 | -1,077 | 532 | 1,755 | Upgrade
|
| Free Cash Flow Per Share | 0.16 | 0.51 | -0.43 | 0.21 | 0.68 | Upgrade
|
| Dividend Per Share | 0.201 | 0.197 | 0.196 | 0.183 | 0.182 | Upgrade
|
| Dividend Growth | 2.03% | 0.51% | 7.10% | 0.55% | 52.69% | Upgrade
|
| Operating Margin | 10.66% | 25.89% | -175.16% | 7.24% | 18.97% | Upgrade
|
| Profit Margin | -6.59% | 4.73% | -118.65% | 0.50% | 7.05% | Upgrade
|
| Free Cash Flow Margin | 7.11% | 19.48% | -61.79% | 3.20% | 10.87% | Upgrade
|
| EBITDA | 747 | 1,778 | -2,901 | 1,326 | 3,165 | Upgrade
|
| EBITDA Margin | 13.68% | 28.31% | -166.44% | 7.97% | 19.60% | Upgrade
|
| D&A For EBITDA | 165 | 152 | 152 | 122 | 102 | Upgrade
|
| EBIT | 582 | 1,626 | -3,053 | 1,204 | 3,063 | Upgrade
|
| EBIT Margin | 10.66% | 25.89% | -175.16% | 7.24% | 18.97% | Upgrade
|
| Effective Tax Rate | 339.31% | 58.75% | - | 88.33% | 28.85% | Upgrade
|
| Revenue as Reported | - | - | - | 17,772 | 15,216 | Upgrade
|
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.